Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
OncoSec Medical Incorporated
Scientific Title
A Multicenter Phase 2, Open-Label Trial of Intratumoral pIL-12 Plus Electroporation in Combination With Intravenous Pembrolizumab in Patients With Stage III/IV Melanoma Who Are Progressing on Either Pembrolizumab or Nivolumab Treatment